Lexeo Therapeutics, Inc. (LXEO) Tops Q2 EPS by 31c
Tweet
Share
E-mailGet Alerts LXEO Hot Sheet
Join SI Premium – FREE
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q2 EPS of ($0.60), $0.31 better than the analyst estimate of ($0.91).
For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- Reading (RDI) Tops Q2 EPS by 4c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
